News

OMA mourns the passing of pioneer of heavy ion therapy Gerhard Kraft

31 March 2023

Ultra-high dose rate radiation production and delivery systems intended for FLASH

30 March 2023

OMA Express Issue 19 now published

23 March 2023

Experimental Validation of a Real-Time Adaptive 4D-Optimized Particle Radiotherapy Approach to Treat Irregularly Moving Tumors

22 March 2023

Adaptix receives 510(k) clearance from the U.S. Food and Drug Administration for its first medical imaging product

06 March 2023

GSI in one of the 10 breakthroughs of 2022: Investigating new weapons in the fight against cancer

25 January 2023

Characterizing a molecular beam curtain for non-invasive beam profile monitor

11 January 2023

IBA wins ten proton therapy system contract in Spain

16 December 2022

EuPRAXIA Doctoral Network to research on laser-driven proton beam therapy

04 November 2022

Newer stories Older Stories

Why choose Liverpool?
It’s an important question. And there are thousands of answers.

Study with Liverpool

Find a course

Search courses

Select type

Our courses

Research with real world impact

Our research

Research

Postgraduate Research

Research and business collaboration

Advancing knowledge to transform lives

About us

Our story

Key information

Our locations

Search

Find a course

Select type

Optimization of Medical Accelerators Project

News

OMA mourns the passing of pioneer of heavy ion therapy Gerhard Kraft

Ultra-high dose rate radiation production and delivery systems intended for FLASH

OMA Express Issue 19 now published

Experimental Validation of a Real-Time Adaptive 4D-Optimized Particle Radiotherapy Approach to Treat Irregularly Moving Tumors

Adaptix receives 510(k) clearance from the U.S. Food and Drug Administration for its first medical imaging product

GSI in one of the 10 breakthroughs of 2022: Investigating new weapons in the fight against cancer

Characterizing a molecular beam curtain for non-invasive beam profile monitor

IBA wins ten proton therapy system contract in Spain

EuPRAXIA Doctoral Network to research on laser-driven proton beam therapy